|
67. The evolution of the social representation of dependence
Dr Michel Hautefeuille, Directeur SERT Marmottan, Paris (France)
73. Study into the outlook for improvements in health-care
for drug addicted women with children at european level.
Implications and consequences
Mr Paolo Stocco , Therapeutic Community “Villa Renata”,
Venise (Italie)
IREFREA European Study Group on “Drug Addiction and Gender
Identity”
81. An experience of service-based evaluation
Mr Russ Hayton, Practice Standards Manager “
Harbour” Integrated Drug and Alcohol services, Plymouth
(UK)
85. The legal policy concerning drug use in europe
Judge Armando Gomez Leandro, Haute-Cour de Justice, Lisbonne
(Portugal)
93. The perception of risk among adults smoking cannabis
M. Pascal Hachet, psychologue, docteur en psychanalyse.
Psychologue au SATO-Picardie, Beauvais, France.
97. Techno and synthesis drugs : the harm reduction
principle as an ethical frame
Mr Jean-Marc Priez, Techno+, Paris (France)
99. HCV and drug addicts
Pr Fernando Ramalho, Lisboa University
and Santa Maria Hospital, Lisboa (Portugal)
103. An in Depth, single case study of a young woman in chaos
Dr Ann Read, Psychiatrist,
Plymouth Community Drug Service, Plymouth (UK)
107.
Psychodynamic aspects of care in a therapeutic community :
the connexion with social re-insertion:
Dr Carlos Vieira, psychologist Communidade da Montanha de Covilha
(Portugal)
113. Why do people take risks in drug markets ?
Dr Karim Murji, criminologist
The Open University, Milton Keynes (UK)
117. Care of drug addicts in hospitals :
what is the position of the substitution treatments ?
Dr Jean-Jacques Pik, Centre d’Accueil et de Soins aux conduites
Addictives (CASA)
Centre Hospitalier de Clermont de l’Oise, Clermont (France)
|